Finch Therapeutics Group Inc (FNCH)
2.23
-0.07
(-3.04%)
USD |
NASDAQ |
May 06, 16:00
2.41
+0.18
(+8.07%)
After-Hours: 07:25
Finch Therapeutics Group Accounts Payable (Quarterly): 0.141M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.141M |
| September 30, 2023 | 0.357M |
| June 30, 2023 | 0.432M |
| March 31, 2023 | 2.553M |
| December 31, 2022 | 1.097M |
| September 30, 2022 | 1.06M |
| June 30, 2022 | 1.013M |
| Date | Value |
|---|---|
| March 31, 2022 | 4.765M |
| December 31, 2021 | 3.737M |
| September 30, 2021 | 1.382M |
| June 30, 2021 | 1.719M |
| March 31, 2021 | 3.878M |
| December 31, 2020 | 2.621M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.141M
Minimum
Dec 2023
4.765M
Maximum
Mar 2022
1.904M
Average
1.382M
Median
Sep 2021
Accounts Payable (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 17.54M |
| Vanda Pharmaceuticals Inc | 7.145M |
| Sage Therapeutics Inc | 6.479M |
| BioSig Technologies Inc | -- |
| Palisade Bio Inc | 0.864M |